Skip to content
The Policy VaultThe Policy Vault

Vosevi (sofosbuvir/velpatasvir/voxilaprevir)Blue Cross Blue Shield of Montana

off-label or compendia-supported uses in Ohio resident members

Initial criteria

  • The member resides in Ohio AND
  • The plan is Fully Insured or HIM Shop (SG) AND BOTH of the following: (A) The patient does NOT have any FDA labeled contraindications to the requested agent AND (B) ONE of the following: (1) The patient has another FDA labeled indication for the requested agent and route of administration OR (2) The patient has another indication supported in compendia for the requested agent and route of administration OR (3) The prescriber has submitted two peer‑reviewed journal articles supporting the proposed use as generally safe and effective

Approval duration

12 months